Roberto Oliveri

Head of Medical Translational Development

Norway

Research Interests

Explore related searches

Professors in Norway

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Roberto Oliveri is the Head of Medical Translational Development at Nykode Therapeutics in Norway. His research primarily focuses on pharmacokinetics and pharmacodynamics, particularly in the context of B-cell lymphomas and multiple sclerosis. Recent publications include work on dose selection for Epcoritamab and the safety and efficacy of mesenchymal stem cells in clinical trials.

Articles (3)

Year:

2022

Year:

2021

Year:

2021

Collaborators (1)

Christopher W. Chiu

Head of Multiple Myeloma and Leukemia TR

J&J Innovative Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Roberto Oliveri

Research Interests

Explore related searches

Contact this professor

About

Articles (3)

Semimechanistic Physiologically-Based Pharmacokinetic/Pharmacodynamic Model Informing Epcoritamab Dose Selection for Patients With B-Cell Lymphomas.

Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial.

Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study.

Collaborators (1)

Christopher W. Chiu

Make your next move.